NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events

NCT04205578 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Moyamoya Disease
Ischemic Cerebral Infarction
Ischemic Stroke
Ischemic Cerebrovascular Accident
Transient Ischemic Attack

Interventions

DRUG: dl-3-n-butylphthalide (NBP)
DRUG: Normal Saline 0.9% Infusion Solution

Sponsor

yuanli Zhao

Collaborators

[object Object]